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N-glycan structures of recombinant human serum transferrin
(hTf) expressed by Lymantria dispar (gypsy moth) 652Y cells
were determined. The gene encoding hTf was incorporated
into a Lymantria dispar nucleopolyhedrovirus (LdMNPV)
under the control of the polyhedrin promoter. This virus was
then used to infect Ld652Y cells, and the recombinant protein
was harvested at 120 h postinfection. N-glycans were released
from the purified recombinant human serum transferrin and
derivatized with 2-aminopyridine; the glycan structures were
analyzed by a two-dimensional HPLC and MALDI-TOF
MS. Structures of 11 glycans (88.8% of total N-glycans)
were elucidated. The glycan analysis revealed that the most
abundant glycans were Man1–3(Fuca6)GlcNAc2 (75.5%)
and GlcNAcMan3(Fuca6)GlcNAc2 (7.4%). There was
only ~6% of high-mannose type glycans identified. Nearly
half (49.8%) of the total N-glycans contained a(1,6)-fucosy-
lation on the Asn-linked GlcNAc residue. However a(1,3)-
fucosylation on the same GlcNAc, often found in N-glycans
produced by other insects and insect cells, was not detected.
Inclusion of fetal bovine serum in culture media had little
effect on the N-glycan structures of the recombinant human
serum transferrin obtained.
Key words: Baculovirus/Gypsy moth/Insect cells/Lymantria
dispar nucleopolyhedrovirus/N-glycan
Introduction
Glycosylation is one of most common posttranslational
modifications made to proteins by eukaryotic cells (Jenkins
and Curling, 1994). Differences in N-glycan structure can
sometimes affect the glycoprotein properties, including
enzymatic activity, antigenicity, stability, solubility, cellular
processing, secretion, and in vivo clearance rate (Varki,
1993). The insect cell-baculovirus expression system has
been widely used for production of a large number of gly-
coproteins because of its ability to express high levels of
heterologous proteins. This protein expression system
primarily uses cell lines established from lepidopteran
insects and the Autographa californica multicapsid nucleo-
polyhedrovirus (AcMNPV)±mediated expression vector
(Summers and Smith, 1987). Lepidopteran-derived insect
cell lines such as Sf9 (from Spodoptera frugiperda) and Tn-
5B1-4 (from Trichoplusia ni) perform many of the post-
translational modifications observed in eukaryotic cells,
including N-glycosylation, and these cells are readily
cultured in suspension in commercially available medium.
Unfortunately, however, most insect cells examined so far
are incapable of synthesizing sialylated complex-type N-
glycans often found in glycoproteins obtained from
mammalian cells.
Earlier studies using dipteran insect cells (Butters and
Hughes, 1981; Hsieh and Robbins, 1984) and lepidopteran
insect cells with the baculovirus system (Kuroda et al., 1990)
indicated that insect cells produce mainly high-mannose-
type and paucimannosidic-type N-glycans. Similar results
have been repeatedly published (Altmann et al., 1999; MaÈrz
et al., 1995). In addition, a(1,3)-fucosylation of Asn-linked
GlcNAc is often observed in insect cell±derived glycopro-
teins, and this modification represents a potential allergen
to humans (Fotisch and Vieths, 2001; Tretter et al., 1993;
Weber et al., 1987). The inability of lepidopteran insect cells
to synthesize sialylated complex-type N-glycans and the
presence of a(1,3)-fucosylation have limited the utility of
insect cells as host cells for production of pharmaceutical
glycoproteins. The limitations of currently used insect cell
lines may potentially be overcome by means of genetic
manipulation to include the necessary processing enzymes
(Ailor et al., 2000; Aumiller and Jarvis, 2002; Breitbach and
Jarvis, 2001; Hollister et al., 1998, 2002; Hollister and
Jarvis, 2001; Tomiya et al., 2003), or by the use of an
alternative insect cell line that may contain mammalian-
like N-glycan processing capabilities.
As an attempt to survey insect cells potentially better
suited for the production of pharmaceutical glycoproteins,
a protein expression system based on a gypsy moth±derived
cell line and a virus, Lymantria dispar multinucleocapsid
nucleopolyhedrovirus (LdMNPV) (Yu et al., 1992), was
tested. LdMNPV was used in the earlier study to express a
bacterial b-galactosidase in tissue culture cells derived from
gypsy moth (Yu et al., 1992). So far, however, the glycosy-
lation pattern of glycoproteins expressed in gypsy moth
cells has not been reported. LdMNPV will infect a number
of cell lines derived from L. dispar, including the cell line
Ld652Y, used in the present study. The Ld652Y cell line1To whom correspondence should be addressed; e-mail: yclee@jhu.edu
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was chosen for the current study because it grows well in
suspension in serum-free media at densities and growth
rates similar to those of other popular insect cells, such as
Sf9 and Tn-5B1-4. In this study, a recombinant human
transferrin (hTf ) was expressed as a model protein in
Ld652Y cells using a recombinant LdMNPV. Structure of
most (~90%) of the N-glycans released from the recombi-
nant hTf was identified by a combination of matrix-assisted
laser desorption/ionization time of flight (MALDI-TOF)
mass spectrometry (MS) and a 2-D mapping technique
(Tomiya et al., 1988).
Results
Expression and purification of recombinant hTf from
gypsy moth cells
Ld652Y cells were grown in shake-flask suspension cultures
up to densities of approximately 7  105 cells/ml of
medium in the presence or absence of 10% fetal bovine
serum (FBS). The cells were then infected at a multiplicity
of infection of one tissue culture infectious dose
(TCID50) per cell with LdMNPV-hTf, which contains the
hTf gene. The recombinant hTf was expressed under the
control of the polyhedrin promoter. At 5 days postinfec-
tion, the culture medium was harvested, and the recombi-
nant hTf was isolated by ammonium sulfate fractionation
and immunoaffinity chromatography using a Sepharose
column onto which anti-hTf antibody was immobilized
(Tomiya et al., 2003). This column bound human serum
transferrin avidly but not bovine serum transferrin (a poten-
tial contaminant from FBS). The purified recombinant hTfs
were examined by sodium dodecyl sulfate±polyacrylamide
gel electrophoresis (SDS±PAGE) followed by Coomassie
blue staining (Figure 1). The recombinant hTfs produced
by Ld652Y cells, with or without serum in the culture
medium, had essentially the same molecular size
(~68 kDa) and showed slightly slower mobility than bovine
transferrin. The results also indicate bovine transferrin
was efficiently removed by the immunoaffinity
chromatography.
Structural analysis of N-glycans of hTf produced
by Ld652Y cells
Detailed glycan analysis was performed with the recombi-
nant hTf obtained under the serum-free culture conditions.
N-glycans were released from the purified hTf after
initial proteolysis using sweet almond glycoamidase A
(Takahashi and Nishibe, 1978), which can remove all
N-glycans including those containing a-Fuc(1-3) sub-
stituted on the Asn-linked GlcNAc (Altmann et al., 1995b;
Fan and Lee, 1997; Takahashi and Tomiya, 1992; Tretter
et al., 1991).
No sialylated glycans were observed when a total mixture
of the released glycans was analyzed by high-performance
anion-exchange chromatography with pulsed ampero-
metric detection (HPAEC-PAD). The released N-glycans
were then reductively aminated with 2-aminopyridine, and
the resultant pyridylamino (PA) derivatives of glycans were
first separated by reversed-phase high-performance liquid
chromatography (HPLC) (Tomiya et al., 1988), from
which 14 peaks were obtained (Figure 2). Each of these
fractions was further separated by normal-phase HPLC
using an amide-silica column (Figure 3). After the two
chromatographic steps, 19 different PA-glycans were iso-
lated. The eight major PA-glycans (7A, 8A, 9A, 10A, 11A,
12A, 13A, and 14A), accounting for 86.5% of the total
glycans, were analyzed by MALDI-TOF MS for confir-
mation. MS spectra of these major glycans are shown in
Figure 4. The elution positions of the major PA-glycans,
together with those of several standard PA-glycans
Fig. 1. SDS±PAGE of the purified hTf expressed in Ld652Y cells. The
purified proteins were analyzed by SDS±PAGE using 10% acrylamide gel
under nonreducing condition. Proteins were stained with Coomassie blue
R-250. M, Marker proteins; 1, native human serum transferrin; 2, bovine
serum transferrin; 3, recombinant hTf expressed in Ld652Y cells in the
serum-free culture medium; 4, recombinant hTf expressed in Ld652Y cells
in the culture medium containing 10% FBS.
Fig. 2. An elution profile (ODS column) of the PA-glycans from the
recombinant hTf expressed in Ld652Y cells in serum-free culture medium.
Fourteen different peaks (1±14) were isolated. The peak marked with a bar
indicates impurities unrelated to N-glycans.
O. Choi et al.
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having related structures, are shown on a 2D map in
Figure 5.
The molecular mass of PA-glycan 7A ([MNa] 
687.95) corresponds to a glycan of one Man and two GlcNAc
residues, suggesting a structure of Manb(1,4)GlcNAcb(1,4)-
GlcNAc, a linear part of the common N-glycan core. Mole-
cular mass of PA-glycans 10A ([MNa]  849.64) is greater
than that of 7A by one Man, and 13A ([MNa]  996.16),
in turn, is greater than 7A by one Fuc. The coordinates of
PA-glycan 10A (7.4 glucose units [GU] on the ODS column
and 3.3 GU on the amide column) on a 2D map coincided
with those of a standard PA-glycan (code no. M2.1),
Mana(1,6)Manb(1,4)GlcNAcb(1,4)GlcNAc-PA (7.4 GU/
3.3 GU) but not with those of a standard PA-glycan
(M2.2), Mana(1,3)Manb(1,4)GlcNAcb(1,4)GlcNAc-PA
(6.3 GU/3.4 GU). The coordinates of PA-glycan 13A (10.4
GU/3.7 GU) coincided with those of a standard PA-glycan
(010.1). Furthermore, the coordinates of 13A shifted to
those of PA-glycan 10A and a standard PA-glycan (M2.1)
after a-L-fucosidase digestion (20 mU, 20 h at 37C), which
removes a(1,6)-linked Fuc but not a(1,3)-linked Fuc from
Asn-linked GlcNAc (Tomiya et al., 2003). The change in the
coordinates (±3.0 GU on the ODS column and ÿ0.4 GU on
the amide column) was also consistent with the unit con-
tribution value of a(1,6)-linked Fuc (3.4 GU/0.4 GU) but
not a(1,3)-linked Fuc (±1.8 GU/1.1GU) attached to Asn-
linked GlcNAc (Tomiya and Takahashi, 1998). These
results suggest that PA-glycans 7A, 10A, and 13A have
the structures shown in Table I.
Molecular masses of PA-glycans 9A ([MNa] 
1011.77) and 12A ([MNa]  1157.98) indicated that 9A
had the common trimannosyl core structure and 12A con-
tained an additional Fuc. The coordinates of PA-glycans
9A on a 2D map coincided with those of a standard PA-
glycan (000.1), and those of PA-glycan 12A coincided with
those of a standard PA-glycan (010.1), but not with those of
a standard PA-glycan (000.1 F) containing Fuca(1,3)
instead of Fuca(1,6) (see Scheme 1).
MS data on PA-glycans 11A ([MNa]  1214.97) indi-
cated that this glycan consisted of the trimannosyl core
structure and an additional GlcNAc on either the
Mana(1,3)- or the Mana(1,6)-branch. Linkage position of
GlcNAc to the trimannosyl core structure in PA-glycan
11A was identified by comparing the coordinates of
PA-glycan 11A on a 2D map with those of the standard
PA-glycans having GlcNAcb(1,2) on either the Mana(1,3)-
branch (100.2) or the Mana(1,6)-branch (100.1). The co-
ordinates on a 2D map of PA-glycan 11A (9.4 GU, 4.6 GU)
was consistent with those of a standard PA-glycan having
the trimannosyl core structure having GlcNAcb(1,2) on the
Fig. 3. 2D HPLC chromatogram of PA-glycans derived from the
recombinant hTf. The peaks from the ODS column (Figure 2) were
subjected to a second separation on a normal phase column (amide-80).
Major (45% of the total glycans) peaks are indicated by circles with
numbers, and their structures are shown (squares, GlcNAc; circles, Man;
triangles, Fuc).
Fig. 4. MALDI-TOF MS spectra of the major PA-glycans from the recombinant hTf expressed in Ld652Y cells. Cells were cultured in serum-free
medium. The eight major PA-glycans were isolated by 2D HPLC (Figure 3), and each fraction (~10 pmol) was subjected to MALDI-TOF MS.
Peak number and measured mass are shown with the calculated mass (in parentheses).
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Mana(1,6)-branch (9.4 GU/4.7 GU) but not with that of
the other isomer having GlcNAcb(1,2) on the Mana(1,3)-
branch (7.4 GU/4.7 GU).
The difference between the MS data of PA-glycans
11A and 14A ([MNa]  1361.02) was equivalent to one
Fuc. The coordinates of PA-glycan 14A on a 2-D map
(12.8 GU, 5.0GU) coincided with those of the following
standard PA-glycan (110.1) within the experimental
error (see Scheme 2). Furthermore, the coordinates of
PA-glycan 14A on a 2D map shifted to those of PA-glycan
11A (and a standard PA-glycan [100.1]) after a-L-fucosi-
dase digestion, and the magnitude of the change in the
coordinates (ÿ3.4 GU/ÿ0.4 GU) was consistent with the
unit contribution value of Fuc, which is a(1,6)-linked to
GlcNAc adjacent to Asn. These results suggest that
PA-glycans 11A and 14A are unfucosylated and a(1,6)-
fucosylated monoantennary glycans, respectively, as shown
in Table I.
Molecular mass of PA-glycan 8A ([MNa]  1336.02)
corresponds to Man5GlcNAc2-PA, a high-mannose-type
Table I. Proposed structures of the N-glycans found in the recombinant human serum transferrin produced by Ld652Y cells cultured in serum-free medium
Structures of glycans shown in bold were identified by MALDI-TOF MS analysis and 2D mapping technique (Tomiya et al., 1988).
Others were identified by comparison of the coordinates on a 2D map of the glycans with those of authentic standard glycans (Tomiya et al., 1991).
Scheme 1. Structures of the reference PA-glycans 000.1, 010.1, and
000.1F. Scheme 2. Structure of the reference PA-glycan 110.1.
O. Choi et al.
542
glycan. The branching structure of this glycan was identi-
fied by comparing the coordinates of PA-glycan 8A with
those of all possible isomers consisting of five Man and two
GlcNAc residues (Tomiya et al., 1991) and further con-
firmed by direct cochromatography with a standard high-
mannose-type PA-glycan (M5.1).
Presence of a(1,3)-fucosylation in the minor glycans (each
~1% of the total glycans) was also investigated by compar-
ison with the known a(1,3)-fucosylated glycans. Figure 6
shows the elution positions of 11 minor PA-glycans and
those of the known glycans having a(1,3)-fucosylated
GlcNAc adjacent to Asn, except xylose-containing glycans
from plants (Takahashi and Tomiya, 1998; Takahashi et al.,
1999; Tomiya et al., 2003). None of these minor PA-glycans
coincided with any of the known PA-glycans containing
Fuca(1,3)GlcNAc linked to Asn, suggesting the absence
of core a(1,3)-fucosylation.
Coordinates of PA-glycans 5A, 2A, and 1C coincided with
those of standard PA-glycans, M6.1, M7.2, and M8.1,
respectively. Structural assignment of these glycans was con-
firmed by comparing their coordinates with those of all
possible isomers consisting of two GlcNAc and six, seven,
or eight Man residues (Tomiya et al., 1991), and by cochro-
matography with standard PA-glycans M6.1, M7.2, or
M8.1. Mass analysis of a total mixture of PA-glycan also
indicated the presence of the low levels of Man6GlcNAc2
([MNa]  1497.74), Man7GlcNAc2 ([MNa]  1663.32),
and Man8GlcNAc2 ([MNa]  1663.32).
In summary, the most abundant glycans were
Man1±3(Fuca6)GlcNAc, representing 75.5% of the total
N-glycans, followed by GlcNAcMan3(Fuca6)GlcNAc2,
representing 7.4% of the total. There was only ~6% of
high-mannose-type glycans identified. Nearly half (49.8%)
of the total N-glycans contained a(1,6)-fucosylation
(12A, 13A, and 14A), but a(1,3)-fucosylation on the Asn-
linked GlcNAc residue could not be detected within
experimental error.
Effects of serum supplementation to the culture medium
on the N-glycosylation of recombinant hTf
N-glycans of hTf from the Ld652Y cells grown in culture
media containing 10% FBS were also analyzed exactly as
described for the product from serum-free medium. The N-
glycan profile on the ODS column showed little difference
between these samples, except the total amount of fucosy-
lated glycans (12A, 13A, and 14A) was slightly increased
from 49.8% to 55.8% in serum.
Discussion
Earlier studies using dipteran insect cells (Butters and
Hughes, 1981; Hsieh and Robbins, 1984) and lepidopteran
insect cells with the baculovirus system (Kuroda et al., 1990)
indicated that insect cells produce mainly high-mannose-
type and paucimannosidic-type N-glycans. Similar results
have been repeatedly shown in subsequent studies (see
Altmann et al., 1999; MaÈrz et al., 1995). When hTf was
expressed in Tn-5B1-4 cells, the distribution of pauciman-
nosidic, high-mannose, and hybrid glycans was 54.0%,
30.8%, and 13.9%, respectively (Ailor et al., 2000).
Compared with the results of other systems, Ld652Y cells
appeared to favor production of high levels of pauciman-
nosidic glycans. The paucimannosidic glycans 7A, 9A, 10A,
12A, and 13A (Table I) represent as much as 76% of the
total N-glycans. The proportion of high-mannose-type gly-
cans (1C, 2A, 5A, and 8A) was very low (6% of the total).
High-mannose-type glycans are commonly found in hetero-
logous glycoproteins from insect cells, especially in intracel-
lular N-glycans (Hsu et al., 1997). The lysis of cells during
the baculovirus infection can lead to the release of proteins
carrying such underprocessed N-glycans into the medium.
In a previous study (Hsu et al., 1997), large amounts of
high-mannose-type glycans were found intracellularly.
This probably was not the case for LdMNPV in this study,
because the cell viability was only ~75% at the harvest time,
but the total high-mannose-type glycans was only ~6%.
It is worth noting that the cell death following viral infec-
tion with LdMNPV is more gradual than that observed
using the AcMNPV virus in the previous studies (data not
shown). Alternatively, Ld652Y cells may include higher
levels of mannosidases, which convert high-mannose-type
structures to paucimannosidic structures. Interestingly,
56% of the total N-glycans (7A, 10A, and 13A) do not
have the Mana1-3GlcNAc branch, and Man1GlcNAc2
(7A), which has only one Man residue, was as high as 7%.
The high proportion of these three N-glycans indicates the
existence of a highly active a(1,3)-mannosidase in Ld652Y
cells.
Ld652Y cells also produced significant amounts of
GlcNAc-terminated N-glycans (7.4% of the total) as did
Tn-5B1-4 cells (Ailor et al., 2000). In Tn-5B1-4 cells, the
N-glycans with GlcNAcb2Mana3 branch were 10% of
the total and those with GlcNAcb2Mana6 branch, 4% of
the total. However, in Ld652Y cells, GlcNAc was found
only in the GlcNAcb2Mana6 branch. It may be that Tn-
5B1-4 cells have a higher GlcNAc transferases I activity
than Ld652Y, and Ld652Y cells have a higher GlcNAc
transferase II activity. Alternatively, the Ld652Y cells may
contain a higher level of N-acetylglucosaminidase than
Tn-5B1-4 cells. An N-acetylglucosaminidase that speci-
fically cleaves terminal GlcNAc residues from the
GlcNAcb2Mana3 branch of N-glycans has been found
in insect cells from Spodoptera frugiperda, Mamestra
brassicae, Bombyx mori, and Trichoplusia ni (Altman et al.,
1995a; Kubelka et al., 1994; Wagner et al., 1996).
Galactosylated N-glycans are generally not found in gly-
coproteins derived from insect cells. Some exceptions
are galactosylated N-glycans in interferon g expressed in
Estigmene acrea cells (Ogonah et al., 1996) and in a mouse
IgG produced by Tn-5B1-4 cells (Hsu et al., 1997).
However, no galactosylated N-glycan was found when
human serum transferrin was expressed in Tn-5B1-4 cells
(Ailor et al., 2000). This is confirmed by the fact that no
detectable change in reverse-phase HPLC was observed
(data not shown) after the total mixture of PA-glycans
was digested by b-galactosidase.
N-glycans containing core a(1,3)-fucosylation were found
in honey bee venom phospholipase A2 and membrane gly-
coproteins from Sf-21, Mb-0503, Bm-N cells (Kubelka et al.,
1994). They were also found in a recombinant mouse IgG
(Hsu et al., 1997) expressed in Tn-5B1-4 cells. On the other
N-glycans of human transferrin from gypsy moth cells
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hand, no core a(1,3)-fucosylation was found in the glycans
of human interferon o expressed in Sf9 cells (Voss et al.,
1993), interferon g expressed in Sf9, and Estigmene acrea
cells (Ogonah et al., 1996). Core a(1,3)-fucosylation was
not found in the third eight-cysteine domain of LTBP-1
(Rudd et al., 2000) expressed in Sf9 cells, but it was present
in the same protein expressed in Tn-5B1-4 cells (Rudd et al.,
2000). a(1,6)-Fucosylation of the Asn-linked GlcNAc is
common in mammalian N-glycans (Kobata, 1992) and
considered innocuous. However, a(1,3)-fucosylation at the
same GlcNAc is not found in mammalian glycoproteins
and can cause an allergic reaction in humans. Furthermore,
the presence of antibodies specific for such a Fuc residue in
human blood can possibly affect in vivo activity and clear-
ance of biopharmaceutical glycoproteins (Bardor et al.,
2003). To have such structures in a glycoprotein makes it
less than ideal for therapeutic use (Prenner et al., 1992;
Wilson et al., 2001).
The choice of glycoamidase A from sweet almond
is important in the current work. It is known that glycoa-
midase A, but not glycoamidase F (from Flavobacter),
can release N-glycans containing the Fuca(1,3)-GlcNAc-
Asn moiety (Altmann et al. 1995b; Fan and Lee,
1997; Takahashi and Tomiya, 1992; Tretter et al., 1991).
Using the glycoamidase A, we previously found that N-
glycans in a recombinant hTf expressed in Tn-5B1-4 cells
contained as much as 6% of difucosylated trimannosyl core
structure (010.1 F) (Ailor et al., 2000), which would have
escaped detection if we had used the Flavobacter enzyme
(see Scheme 3).
Even with the use of glycoamidase A, we could not detect
any glycan containing core a(1,3)-fucosylation in the pre-
sent study. However, the Ld652Y cells may still produce
very low levels of core a(1,3)-fucosylated glycans that
escaped our detection. At any rate, the present study sug-
gests that the levels of core a(1,3)-fucosylation in Ld652Y
cells are negligible or very much lower than that found in
Tn-5B1-4 cells. This may be an advantage if gypsy moth±
derived cell lines are to be used for glycoprotein production
for human use.
Insect cells can grow in serum-containing, serum-free, or
even protein-free growth medium. Our results show that
inclusion of FBS did not affect N-glycosylation patterns in
Ld652Y cells except for a small increase in a(1,6)-fucosy-
lated glycans. Elimination of serum from the culture med-
ium will further contribute to lowering the production costs
of glycoproteins.
Mammalian cells express sialylated complex-type N-
glycans on glycoproteins, but Ld652Y cells, like most
other insect cell lines, lack the capacity to produce
complex-type N-glycans containing Gal and sialic acid resi-
dues. Other modifications leading to complex-type struc-
tures (including tri- and tetraantennary structures), are also
not present in Ld652Y cells. To produce more `` humanized''
glycoproteins in insect cells, such deficiencies must be
overcome. These include elimination of core a(1,3)-
fucosylation, enhancement of GlcNAc transferases I
and II, and b(1,4)-galactosyltransferase activity, introduc-
tion of the sialylation module (Altmann et al., 1999;
Hollister et al., 2002; Lawrence et al., 2000; Laurence et al.,
2001) and suppression of a certain specific b-N-acetylgluco-
saminidase activity (Altman et al., 1995a; Watanabe et al.,
2002). More `` mammalian-like'' N-glycans are being
produced in insect cells by the introduction of genes of
processing-related enzymes (Ailor et al., 2000; Aumiller
and Jarvis, 2002; Breitbach and Jarvis, 2001; Hollister et
al. 1998, 2002; Hollister and Jarvis, 2001; Tomiya et al.,
2003). Gypsy moth±derived cell lines may become a
preferable target for genetic engineering if the lack of a(1-
3)-fucosylation can be profitably utilized.
Materials and methods
Materials
Excell 420 medium was purchased from JRH Biosicence
(Lenexa, KS). FBS and the appropriate cloning kit
and restriction enzymes were obtained from Invitrogen
(Carlsbad, CA). Glycoamidase A (glycopeptidase A, EC
3.5.1.52) from sweet almond was from Seikagaku
America (Falmouth, MA); jack bean b-galactosidase,
jack bean b-N-acetylhexosaminidase, bovine kidney
a-L-fucosidase, 2-aminopyridine, sodium cyanoboro-
hydride, and apo-human transferrin were from Sigma-
Aldrich (St. Louis, MO). Dowex 50 2 (H) and
Sephadex G-15 (medium) were from Dow Chemical
(Midland, MI). Shim-pack CLC-ODS column (6 150
mm) was from Shimadzu USA (Columbia, MD). Amide-
80 column (4.6 250 mm) was from Tosoh Biosep
(Montgomeryville, PA).
Generation of a recombinant hTf-expressing virus
strain of LdMNPV
Polyh-htf-pMT/V5-His was constructed to contain the hTf
gene (Yang et al., 1984) with accompanied sequence at the
30 end to generate a V5 tag as well as six histidine residues
under the control of the LdMNPV polyhedrin promoter
(Bischoff and Slavicek, 1996). The following sequence was
added to the 30 end of the hTf gene to generate the V5
epitope and the six his tag: CTC GAG TCT AGA GGG
CCC TTC GAA GGT AAG CCT ATC CCT AAC CCT
CTC CTC GGT CTC GAT TCT ACG CGT ACC GGT
CAT CAT CAC CAT CAC CAT TGA.
To generate a transplacement vector for construction of a
recombinant virus, cosmid clone P313 (Riegel et al., 1994)
was digested with BamHI and HindIII, and the 9294-bp
fragment from 128,400±137,694 (Kuzio et al., 1999)
was cloned into the BamHI and HindIII sites of pBS
sk to generate pNP-EGT-9.3. The pNP-EGT-9.3 was
digested with BsteII and blunt ended with Klenow.
The polyh-htf-pMT/V5-His was digested with SpeI and
PmeI, and the SpeI/PmeI fragment was isolated and the
ends were filled with Klenow. The SpeI/PmeI fragment
from clone polyh-htf-pMT/V5-His was ligated into theScheme 3. Structure of a difucosylated trimannosyl core structure.
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BsteII digested pNP-EGT-9.3 to generate the transplace-
ment vector polyh-htf-his6EGT-. This transplacement
vector contains the gene and lacks most of the EGT gene
(from 120,641±121,613). Viral strain 122bEGT-LacZ
was used to generate a recombinant LdMNPV strain
expressing the hTf gene (Slavicek et al., 2001). This viral
strain had the LacZ gene in place of the EGT gene. Viral
isolate 122bEGT-LacZ genomic DNA and the trans-
placement vector polyh-htf-his6EGT- were cotransfected
into Ld652Y cells as described previously (Bischoff and
Slavicek, 1996). Budded virus from the transfection was
plaque-purified, and several clear plaques were isolated
and plaque-purified again. The purified viral isolates were
propagated in Ld652Y cells; genomic DNA was isolated
and analyzed by restriction endonuclease digestion (data
not shown).
Cell culture and virus infection
Ld652Y cells established from L. dispar and LdMNPV were
used as a host and virus system. The cells were maintained
as described previously (Bischoff and Slavicek, 1996). A
suspension culture of Ld652Y cells was maintained at
27C and rotated at 120 rpm in 250-ml shaker flasks con-
taining 30 ml Excell 420 media. For the recombinant hTf
production, 10 100-ml shake flasks, containing serum-free
Excell 420 media with or without 10% FBS, were seeded
with 7  107 Ld652Y cells. The cells were infected with
LdMNPV-hTf at 1.0 tissue culture infectious dose (TCID50)
unit per cell. TCID50 was determined as described pre-
viously (Slavicek et al., 2001). The cells were incubated at
27C and rotated at 120 rpm. Five days postinfection, the
culture media containing hTf were harvested after removal
of cells by centrifugation.
Purification of recombinant hTf from culture medium
The culture supernatant containing hTf (1 L) was concen-
trated by ultrafiltration, and proteins were precipitated by
adding ammonium sulfate (50% final saturation). After
removing the precipitate by centrifugation at 8000 rpm for
15 min at 4C, proteins including hTf were precipitated by
adding ammonium sulfate to the supernatant (80% final
saturation) and collected by centrifugation. The precipitate
was dissolved in buffer A (10 mM Tris±HCl, pH 7.0), and
dialyzed against buffer A at 4C. The hTf-containing sam-
ple solution was then applied to a column (f1.6  6 cm) of
anti-hTf-IgG immobilized Sepharose 4 Fast Flow (Tomiya
et al., 2003) equilibrated with buffer A containing 0.5 M
NaCl. After unbound proteins were washed off with the
same buffer, hTf was eluted with 0.1 M glycine±HCl, pH
2.7, containing 0.5 M NaCl. The eluate was immediately
neutralized with 0.5 M Tris±HCl, pH 8.3, dialyzed against
water, lyophilized, and used for carbohydrate analyses. The
purity of the recombinant hTf preparation was analyzed by
SDS±PAGE (10% acrylamide) under nonreducing condi-
tion, and proteins were visualized by Coomassie brilliant
blue R-250 staining.
Purification and derivatization of N-glycans from
recombinant hTf
N-glycans were prepared from the purified recombinant hTf
as described previously (Ailor et al., 2000). Briefly, a tryp-
sin-chymotrypsin (each 1%, w/w, of the substrate protein)
digest of hTf (5 mg) was treated with glycoamidase A
(0.4 mU) in 100 mM sodium citrate-phosphate, pH 5, at
37C overnight, and the mixture was passed through a
Scheme 4. Structures of the reference PA-glycans used for analysis of the
major glycans shown in Figure 5.
Fig. 5. 2D map aided structural characterization of the major glycans from
the recombinant hTf expressed by Ld652Y cells cultured in serum-free
medium. The arrows indicate the changes in the coordinates of PA-glycans
by a-L-fucosidase digestion. Symbols: circles, major glycans from
recombinant hTf; plus signs, reference PA-glycans. Structures of the
reference PA-glycans are as follows. M, Man; GN, GlcNAc; F, Fuc.
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Dowex 50  2 (H) column (1 ml). The purified glycans in
the effluent thus obtained were lyophilized and derivatized
by reductive amination with 2-aminopyridine and sodium
cyanoborohydride (Nakagawa et al., 1995; Yamamoto et
al., 1989), and the PA-derivatized glycans were purified by
gel filtration on a Sephadex G-15 column (1.0  40 cm)
using 10 mM NH4HCO3 as eluant.
Isolation and characterization of PA-glycans by two
different HPLC steps
The LC-10A HPLC system (Shimadzu USA) was used
to analyze the PA-glycans. The PA-glycan mixture was
separated and characterized by 2D sugar mapping techni-
que as described previously (Takahashi et al., 1995;
Tomiya et al., 1988). PA-derivatized glycans were moni-
tored by fluorescence (eex 300 nm, eem 360 nm). The
HPLC conditions for analytical chromatography with two
columns were the same as described previously (Tomiya
et al., 1988). The PA-glycans were successively separated
on a reverse-phase column, Shim-pack CLC-ODS (6 
150 nm), and a normal phase column, Amide-80 (4.6 
250 mm). The elution time normalized as the elution
position of GU, based on elution positions of PA-
isomalto-oligosaccharides (DP 4±20). The elution times
(in min) of the glycans of interest in ODS and amide-
80 column chromatography were converted to GU and
plotted on the x-axis (ODS column) and y-axis (amide-80
column). The resultant 2D map for all PA-glycans
was compared with those of known PA-glycans and con-
firmed by cochromatography with reference glycans.
The reference glycans were obtained from human im-
munoglobulin G, ribonuclease B, and recombinant hTf
expressed in T. ni cells using the same procedure (Tomiya
et al., 2003).
MALDI-TOF MS analysis
The Kompact SEQ MALDI-TOF mass spectrometer
(Kratos Analytical, Manchester, UK) was used to
analyze PA-glycans in the linear positive-ion mode using
20 mg/ml of 2,5-dihydroxybenzoic acid as reported
previously (Papac et al., 1998). The matrix was dissolved
in a 1:1 (v/v) mixture of ethanol:10 mM sodium chloride.
To crystallize the sample PA-glycans, 0.5 ml of the matrix
was placed on a sample plate to which 0.5 ml of the
sample (usually 10 pmol) followed by 0.5 ml of
matrix were added, and air-dried. A mixture of PA-iso-
malto-oligosaccharides (DP 4±20) was used for
calibration.
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